Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: Evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1298-1306

  Mohamed Ali, Qurashi ^a   Elwali, Nasr Eldin M A ^d   Abdelhameed, Ahmed A ^d   Mergani, Adil ^d   Rahoud, Siddig ^d   Elagib, Kamal E ^d   Saeed, Osman K ^d   Abel, Laurent ^b   Magzoub, Mubarak M A ^d   Dessein, Alain J ^b,c  

^a ALZAIEM ALAZHARI UNIVERSITY   (Sudan)

^b INSERM   (France)

^c Aix Marseille university   (France)

^d Faculté de Médecine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE COURSE; DISEASE PREDISPOSITION; ENDEMIC DISEASE; FEMALE; HUMAN; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEDIGREE ANALYSIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPLENOMEGALY;

EID: 0033402375     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314999     Document Type: Article

References (43)

1. Bogliolo L. Sobre a quadro anatomico do figado na forma hepatoesplenica da esquistossomose mansonica. Hosp Rio Janeiro 1954;45:283-306.
2. Symmers W, Note on a new form of liver cirrhosis due to the presence of the ova of Bilharzia hematobia. J Pathol 1904;9:237-9.
3. Kloetzel K, Splenomegaly in schistosomiasis mansoni. Am J Trop Med Hyg 1962;25:273-84.
4. Arap Siongok TK, Mahmoud AA, Ouma JK, et al. Morbidity in schistosomiasis mansoni in relation to intensity of infection: study of a community in Machakos, Kenya. Am J Trop Med Hyg 1976;25:273-84.
5. Gryseels A. Morbidity due to schistosomiasis mansoni and its control in Subsaharan Africa. Parasitol Today 1991;7:244-8.
6. Sleigh AC, Mon KE, Hoff R, et al. Three-year prospective study of the evolution of Manson's schistosomiasis in northeast Brazil. Lancet 1985; 2:63-6.
7. Tavares-Neto J, Prata A. Coeficiente de endocruzamento em portadores de esquistossomose mansônica. Rev Soc Bras Med Trop 1989;225-9.
8. Tavares-Neto J, A. P. Family occurrence of schistosomal hepatosplenomegaly and maternal effect. Rev Soc Bras Med Trop 1989;22:13-8.
9. Abaza H, Asser L. el Sawy M, et al. HLA antigens in schistosomal hepatic fibrosis patients with haematemesis. Tissue Antigens 1985;26:307-9.
10. Abdel-Salam E, Abdel Khalik A, Abdel-Meguid A, Barakat W, Mahmoud AA. Association of HLA class I antigens (Al, B5, B8 and CW2) with disease manifestations and infection in human schistosomiasis mansoni in Egypt. Tissue Antigens 1986;27:142-6.
11. Cabello PH, Krieger H, Lopes JD, Sant Ana EJ. On the association between HLA-Al and B5 and clinical forms of schistosomiasis mansoni. Mem Inst Oswaldo Cruz 1991;86:37-40.
12. Salam EA, Ishaac S, Mahmoud AA. Histocompatibility-linked susceptibility for hepatosplenomegaly in human schistosomiasis mansoni. J Immunol 1979;123:1829-31.
13. Secor WE, del Corral H, dos Reis MG, et al. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. J Infect Dis 1996;174:1131-5.
14. Abdel-Wahab ME Esmat G. Milad M, Abdel-Rezek S, Strickland GT. Characteristic sonographic pattern of schistosomal hepatic fibrosis. Am J Trop Med Hyg 1989;40:72-6.
15. Abdel-Wahab MF, Esmat G, Narooz. SI, Yosery A, Struewing JP, Strickland GT. Sonographic studies of schoolchildren in a village endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg 1990;84:69-73.
16. Cerri GG, Alves VA, Magalhaes A. Hepatosplenic schistosomiasis mansoni: ultrasound manifestations. Radiology 1984;153:777-80.
17. Dochring-Schwerdtfeger E, Abdel-Rahim IM, Mohamed-Ali Q. et al. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: evaluation of morbidity. Am J Trop Med Hyg 1990;42:581-6.
18. Homeida M, Ahmed S, Dafalla A, et al. Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. Am J Trop Med Hyg 1988;39:196-201.
19. Homeida M, Abdel-Gadir AF, Cheever AW, et al. Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: a prospective blinded study. Am J Trop Med Hyg 1988;38:86-91.
20. Group TCW. The use of diagnostic ultrasound in schistosomiasis attempts al standardization of methodology, Cairo Working Group. Acta Trop 1992;51:45-63.
21. Richter J, Monteiro EdS, Braz RM, et al. Sonographic organometry in Brazilian and Sudanese patients with hepatosplenic schistosomiasis mansoni and its relation to the risk of bleeding from oesophageal varices, Acta Trop 1992;51:281-90.
22. Doehring-Schwerdtfeger E, Kaiser C, Schlake J, et al. Ultrasound versus clinical examination us indication for Schistosoma mansoni associated morbidity in children. Trop Med Parasitol 1992;43:245-8.
23. Dittrich M, Milde S. Dinkel E, Baumann W, Weitzel D, Sonographic biometry of liver and spleen size in childhood. Pediatr Radiol 1983;13:206-11.
24. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972;14:307-400.
25. Omer AK, Hamilton PJ, Marshall TF, Draper CC. Infection with Schistosoma mansoni in the Gezire area of the Sudan, J Trop Med Hyg 1976;79:151-7.
26. Dessein AJ, Begley M, Demeure; C, et al. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J Immunol 1988;140:2727-36.
27. Dessein AJ, Couissinier P, Demeure T, et al. Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni. Immunol Invest 1992;21:423-53.
28. Abel L, Demenais F, Prata A, Souza AE, Dessein A. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni [use comments]. Am J Hum Genet 1991;48:959-70.
29. Bina J, Prata A, Regressao da hepatosplenomegalia pelo tratamento especifico da esquitossomose. Rev Soc Bras Med Trop 1983;16:213-8.
30. Abdel-Latif Z, Abdel-Wahab MF, El-Kady NM. Evaluation of portal hypertension in cases of hepatosplenic schistosomiasis using ultrasound. J Clin Ultrasound 1981;9:409-12.
31. Richter J, Zwingenberger K, Ali QM, et al. Hepatosplenic schistosomiasis: comparison of monographic findings in Brazilian and Sudanese patients-correlation of sonographic findings with clinical symptoms. Radiology 1992;184:711-6.
32. Hammad TA, Gabr NS, Hussein MH, Orieby A, Shawky E, Strickland GT. Determinants of infection with schistosomiasis haematobia using logistic regression. Am J Trop Med Hyg 1997;57:464-8.
33. Firmo JO, Lima Costa MF, Guerra HL, Rocha RS. Urban schistosomiasis: morbidity, sociodemographic characteristics and water contact patterns predictive of infection. Int J Epidemiol 1996;25:1292-300.
34. Parraga IM, Assis AM, Prado MS, et al. Gender differences in growth of school-aged children with schistosomiasis and geohelminth infection. Am J Trop Med Hyg 1996;55:150-6.
35. Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-γ promoter. J Immunol 1991;146:4362-7.
36. Araneo BA, Dowell T, Diegel M, Daynes KA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4). IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood 1991;78:688-99.
37. Mallat A, Preaux AM, Blazejewski S, Rosenbaum J, Dhumeaux D, Mavier P. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 1995;21:1003-10.
38. Czaja MJ, Weiner FR, Takahashi S, et al. Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 1989;10:795-800.
39. Lortat-Jacob H, Baltzer F, Desmouliere A, Peyrol S, Grimaud JA. Lobular -but not periovular - inhibition of collagen deposition in the liver of S. mansoni infected mice using interferon-gamma. J Hepatol 1997;26:894-903
40. Cheever AW. A quantitative post-mortem study of schistosomiasis mansoni in man. Am J Trop Med Hyg 1968;17:38-64.
41. Dessein AJ, Hillaire D, Eldin N, et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-γ receptor gene. Am J Hum Genet 1999;65:709-21.
42. Marquet S, Abel L, Hillaire D, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996;14:181-4.
43. Marquet S, Abel L, Hillaire D, Dessein A. Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome Sq31-q33. Eur J Hum Genet 1999;7:88-97.